![]() Updated Pneumococcal Conjugate Vaccine Information Statement (VIS) postedįDA approves the first respiratory syncytial virus (RSV) vaccine. Updated Hepatitis B Vaccine Information Statement (VIS) posted Abrysvo is approved for individuals 60 years of age and older. ![]() CDC posts new Respiratory Syncytial Virus (RSV) Vaccine Information StatementĬDC posts updated Multiple Vaccines (“Your Child’s First Vaccines”) Vaccine Information StatementĪCIP recommendations on use of Respiratory Syncytial Virus (RSV) vaccines (Pfizer Abrysvo and GSK Arexvy) in older adultsįDA approves Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted - Emergent BioSolutions) a two-dose anthrax vaccine for post-exposure prophylaxis use for adults 18 through 65 yearsĬDC adopts 2023-24 ACIP flu vaccination recommendations, to be published later this summerĬDC recommends RSV vaccine for older adults using shared clinical decision-makingĪCIP interim recommendations for use of bivalent mRNA vaccines for persons aged 6 months – 5 years, adults 65 and older, and for those with immunocompromising conditionsįDA approves Abrysvo (Pfizer) respiratory syncytial virus (RSV) vaccine. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |